2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid

C67H78F2N14O12S2 — CID 159027758

IUPAC2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
SMILESNCCCC[C@@H]1NC(=O)CCSCc2cccc(c2)CSCCNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)CNC1=O
InChIInChI=1S/C67H78F2N14O12S2/c68-43-11-15-49-47(27-43)41(31-73-49)25-52-62(90)79-53(26-42-32-74-50-16-12-44(69)28-48(42)50)63(91)81-55(30-60(87)88)65(93)80-54(29-45-33-71-37-76-45)64(92)82-56(24-38-9-13-46(84)14-10-38)67(95)83-20-4-8-57(83)66(94)72-19-22-97-36-40-6-3-5-39(23-40)35-96-21-17-58(85)77-51(7-1-2-18-70)61(89)75-34-59(86)78-52/h3,5-6,9-16,23,27-28,31-33,37,51-57,73-74,84H,1-2,4,7-8,17-22,24-26,29-30,34-36,70H2,(H,71,76)(H,72,94)(H,75,89)(H,77,85)(H,78,86)(H,79,90)(H,80,93)(H,81,91)(H,82,92)(H,87,88)/t51-,52-,53-,54-,55-,56-,57-/m0/s1
InChIKeyJUMIZFILSSYEFV-CXOSAIITSA-N
MW1373.58 g/mol
LogP2.93
Rot. Bonds14

About 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid

2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (PubChem CID 159027758) has the molecular formula C67H78F2N14O12S2 and a molecular weight of 1373.58 g/mol. Its IUPAC name is 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.

Molecular Properties

Compound Name2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
PubChem CID159027758
Molecular FormulaC67H78F2N14O12S2
Molecular Weight1373.58 g/mol
Exact Mass1372.53
IUPAC Name2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid
SMILESNCCCC[C@@H]1NC(=O)CCSCc2cccc(c2)CSCCNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)CNC1=O
InChIInChI=1S/C67H78F2N14O12S2/c68-43-11-15-49-47(27-43)41(31-73-49)25-52-62(90)79-53(26-42-32-74-50-16-12-44(69)28-48(42)50)63(91)81-55(30-60(87)88)65(93)80-54(29-45-33-71-37-76-45)64(92)82-56(24-38-9-13-46(84)14-10-38)67(95)83-20-4-8-57(83)66(94)72-19-22-97-36-40-6-3-5-39(23-40)35-96-21-17-58(85)77-51(7-1-2-18-70)61(89)75-34-59(86)78-52/h3,5-6,9-16,23,27-28,31-33,37,51-57,73-74,84H,1-2,4,7-8,17-22,24-26,29-30,34-36,70H2,(H,71,76)(H,72,94)(H,75,89)(H,77,85)(H,78,86)(H,79,90)(H,80,93)(H,81,91)(H,82,92)(H,87,88)/t51-,52-,53-,54-,55-,56-,57-/m0/s1
InChIKeyJUMIZFILSSYEFV-CXOSAIITSA-N
XLogP2.93
TPSA396.92 Ų
H-Bond Donors14
H-Bond Acceptors15
Rotatable Bonds14
Heavy Atoms97
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001373.58
LogP ≤ 52.93
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The IUPAC name of 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid (CID 159027758) is 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid.
What is the SMILES notation for 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The canonical SMILES for 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is NCCCC[C@@H]1NC(=O)CCSCc2cccc(c2)CSCCNC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)[C@H](Cc2c[nH]c3ccc(F)cc23)NC(=O)CNC1=O.
What is the InChIKey of 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
The InChIKey is JUMIZFILSSYEFV-CXOSAIITSA-N. The full InChI is InChI=1S/C67H78F2N14O12S2/c68-43-11-15-49-47(27-43)41(31-73-49)25-52-62(90)79-53(26-42-32-74-50-16-12-44(69)28-48(42)50)63(91)81-55(30-60(87)88)65(93)80-54(29-45-33-71-37-76-45)64(92)82-56(24-38-9-13-46(84)14-10-38)67(95)83-20-4-8-57(83)66(94)72-19-22-97-36-40-6-3-5-39(23-40)35-96-21-17-58(85)77-51(7-1-2-18-70)61(89)75-34-59(86)78-52/h3,5-6,9-16,23,27-28,31-33,37,51-57,73-74,84H,1-2,4,7-8,17-22,24-26,29-30,34-36,70H2,(H,71,76)(H,72,94)(H,75,89)(H,77,85)(H,78,86)(H,79,90)(H,80,93)(H,81,91)(H,82,92)(H,87,88)/t51-,52-,53-,54-,55-,56-,57-/m0/s1.
What are the key properties of 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid?
2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid has a molecular weight of 1373.58 g/mol, XLogP of 2.93, 14 rotatable bonds, 14 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(8S,14S,17S,20S,23S,26S,32S)-32-(4-aminobutyl)-23,26-bis[(5-fluoro-1H-indol-3-yl)methyl]-14-[(4-hydroxyphenyl)methyl]-17-(1H-imidazol-5-ylmethyl)-7,13,16,19,22,25,28,31,34-nonaoxo-3,37-dithia-6,12,15,18,21,24,27,30,33-nonazatricyclo[37.3.1.08,12]tritetraconta-1(42),39(43),40-trien-20-yl]acetic acid is sourced from PubChem (CID 159027758), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).